The overall goal of this work is to apply Dixon fat-water MRI to test fundamental hypotheses regarding the role of elevated adiposity in breast cancer treatment-related lymphedema (BCRL) condition severity. BCRL is a common co-morbidity of breast cancer therapies, yet factors that contribute to BCRL progression remain incompletely characterized. We observed that adiposity quantified by MRI is elevated in the affected upper extremity and torso of women with BCRL and increases with condition severity. As such, Dixon MRI may provide a surrogate marker of BCRL onset and may help to inform the varied course of lymphedema progression.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords